Protara Therapeutics, Inc. (TARA) Tops Q3 EPS by 29c

Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q3 EPS of ($0.68), $0.29 better than the analyst estimate of ($0.97).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.

You May Also Be Interested In

• Is Treasury selloff a major issue for stock market bulls?
• Yum! Brands (YUM) PT Lowered to $180 at Argus
• Vislink Technologies Inc. (VISL) Misses Q2 EPS by 7c